Triplex forming oligonucleotide targeted to 3′UTR downregulates the expression of the bcl-2 proto-oncogene in HeLa cells

Nucleic Acids Research

Volumn 29, Issue 3, 2001, Pages 622-628

  Shen, Changxian ^a   Buck, Andreas ^a   Mehrke, Gerhard ^a   Polat, Bülent ^a   Gross, Hans Jügen ^a   Bachem, Max ^a   Reske, Sven ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; OLIGONUCLEOTIDE; PHOSPHOROTHIOIC ACID; PROTEIN BCL 2;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; ASSAY; CANCER; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE TARGETING; GENE THERAPY; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PLASMID; PRIORITY JOURNAL; PROTO ONCOGENE; WESTERN BLOTTING;

EID: 0035253778     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/29.3.622     Document Type: Article

References (41)

1. Triplex DNA: Fundamentals, advances, and potential applications for gene therapy
2. Triplex DNA structures
3. Second structural motif for recognition of DNA by oligonuleotide-directed triple-helix formation
4. Sequence specificity in triple-helix formation: Experimental and theoretical studies of the effect of mismatches on triplex stability
5. Binding of triple helix forming oligonucleotides to sites in gene promoters
6. Binding of DNA oligonucleotides to sequences in the promoter of the human bcl-2 gene
7. Inhibition of transcription elongation in the HER-2/neu coding sequence by triplex-directed covalent modification of the template strand
8. Investigation of the intracellular stability and formation of a triple helix formed with a short purine oligonucleotide targeted to the murine c-pim-1 proto-oncogene promoter
9. A novel triplex-forming oligonucleotide targeted to human Cyclin D1 (bcl-1, proto-oncogene) promoter inhibits transcription in HeLa cells
10. Inhibition of transcription of the human c-myc protooncogene by intermolecular triplex
11. Antiparallel polypurine phosphorothioate oligonucleotides form stable triplexes with the rat α1(I) collagen gene promoter and inhibit transcription in cultured rat fibroblasts
12. Deoxyribonucleic acid triplex formation inhibits granulocyte macrophage colony-stimulating factor gene expression and suppression growth in juvenile myelomonocytic leukemic cells
13. Suppression of insulin-like growth factor type I receptor by a triple-helix strategy inhibits IGF-I transcription and tumorigenic potential of rat C6 glioblastoma cells
14. Accessibility of nuclear DNA to triplex-forming oligonucleotides: The integrated HIV-1 provirus as a target
15. Triplex targeting of a native gene in permeabilized intact cells: Covalent modification of the gene for the chemokine receptor CCR5
16. Detection of covalent triplex within human cells
17. Mutagenesis in mammalian cells induced by triple helix formation and transcription-coupled repair
18. Like attracts like: Getting RNA processing together in the nucleus
19. The 3′-untranslated region of messenger RNA: A molecular 'hotspot' for pathology?
20. Interfering with gene expression
21. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death
22. Bcl-2 gene promoters haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
23. Bcl-2 family proteins: Regulators of apoptosis and chemoresistance in hematologic malignancies
24. The chromosomal basis of human neoplasia
25. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation
26. Expression of Bcl-2 and Bcl-2-Ig fusion transcripts in normal and neoplastic cells
27. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma
28. Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-Ig fusion gene in lymphoma
29. π1 binding sites are negative regulators of bcl-2 expression in pre-B cells
30. A cis-acting element in the BCL-2 gene controls expression through translational mechanisms
31. Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis
32. The human immunodeficiency virus type-1 Tat protein upregulates Bcl-2 gene expression in Jurkat T-cell lines and primary peripheral blood mononuclear cells
33. WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene
34. A potent cell death activity associated with transient high level expression of BCL-2
35. Tetracycline-controlled gene expression system achieves high-level and quantitative control of gene expression
36. Stable triple helices formed by oligonucleotide N3′→P5′ phosphoramidates inhibit transcription elongation
37. Inhibition of transcription of HIV-1 in infected human cells by oligodeoxynucleotides designed to form DNA triple helices
38. Inhibition of nuclear protein binding to the human Ki-ras promoter by triplex-forming oligonucleotides
39. Triplex formation inhibits HER-2/neu transcription in vitro
40. Inhibition of in vitro transcription by a triplex-forming oligonuleotide targeted to human c-myc P2 promoter
41. Inhibition of DNA binding proteins by oligonucleotide-directed triple helix formation